Oscar-winning director Steven Soderbergh’s new movie “Logan Lucky” hits U.S. theaters in two weeks, from the independent distributor Bleecker Street — but that’s not how Soderbergh wanted it.The filmmaker has been trying to convince American theater chains to release his films without the benefit of a studio distributor for years, an insider told TheWrap.Soderbergh’s open and gleeful disgust with the movie business has nearly eclipsed the promotional tour for “Logan Lucky.”To finance the film, which stars Channing Tatum, Daniel Craig and Adam Driver, Soderbergh raised $29 million by personally selling its international distribution rights, a second insider told TheWrap. Soderbergh’s company guaranteed Bleecker roughly $1 million to put the movie in theaters and execute a marketing plan dictated by Soderbergh, the insider said.All these people who work for scale to make this film will literally be able to go online with a password and look at this account as the money is delivered from the theaters.
NYS Entity Status
NYS Filing Date
DECEMBER 18, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - BLEECKER STREET VENTURES, LLC
AROUND THE WEB
- Inside Steven Soderbergh’s Plan to Make Hollywood Studios Obsolete
By Matt Donnelly, provided by
- Wednesday Aug 2, 2017
- Listing of the Day: New York
Friday Jul 21, 2017
The colonial-style home in Westchester, New York played host to the wedding of Marilyn Monroe and playwright Arthur Miller.
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Ask the NY Giants: Socks with Sandals?
Tuesday Sep 15, 2015
Professional athletes like members of the New York Giants are the inspiration for the latest (counterintuitive) high-fashion trend: wearing socks with sandals. Photo: Stu Woo/The Wall Street Journal
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]